Product introduction
Svitinib 12.5 Capsule is a medicine used in the treatment of kidney cancer and gastrointestinal stromal tumor. It works by blocking specific enzymes that promote the growth of cancer cells. This way it shrinks the tumor and slows down its progression.
Svitinib 12.5 Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Common side effects of this medicine include weakness, diarrhea, nausea, vomiting, taste change, and decreased appetite. The doctor may advise for regular monitoring of blood pressure and thyroid gland function while taking this medicine. It may decrease blood sugar levels. In fact, the levels can decrease to the extent that the patient may faint. So, if you are diabetic then it is important to check your blood sugar levels regularly. Additionally, you should also consult the doctor if the dose of anti-diabetic medicines needs to be adjusted.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or bleeding disorder. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Uses of Svitinib Capsule
- Kidney cancer
- Gastrointestinal stromal tumour
Benefits of Svitinib Capsule
In Kidney cancer
Side effects of Svitinib Capsule
Common side effects of Svitinib
- Decreased appetite
- Mucositis
- Skin discoloration
- Hand-foot-and-mouth disease
- Change in color of hair
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Increased aspartate aminotransferase
- Increased alanine aminotransferase
- Increased lipase in the blood
- Increased creatinine level in blood
- Decreased in left ventricular ejection fraction
- Decreased potassium level in blood
- Increased sodium level in blood
- Mouth pain
- Tongue pain
- Piles
- Pain in extremity
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased bilirubin in the blood
- Dryness in mouth
- Hand-foot syndrome
- Bleeding disorder
- Nausea
- Vomiting
- Abdominal pain
- Rash
- Weakness
- Fatigue
- Flatulence
- Bleeding
- Insomnia (difficulty in sleeping)
- Diarrhea
- Constipation
- Taste change
- Hair loss
- Decreased level of thyroid hormones
- High blood pressure
- Muscle pain
- Fever
- Cough
- Breathlessness
- Back pain
- Weight loss
How to use Svitinib Capsule
How Svitinib Capsule works
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving
Svitinib 12.5 Capsule may cause dizziness during the treatment. Do not drive or operate machineries if you experience this while on treatment with the medicine.

Kidney

Liver
What if you forget to take Svitinib Capsule?
Quick tips
- Svitinib 12.5 Capsule is used for the treatment of thyroid cancer.
- Take it with or without food, preferably at the same time each day.
- Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn’t stop or if you find blood in your stools.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
- It may affect wound healing time. Be careful while shaving, cutting fingernails or toenails, or using sharp objects.
- Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, confusion, problems with your eyesight, nausea or vomiting.
- Monitoring of thyroid gland function is required while taking this medicine. Inform your doctor if you notice symptoms of weight gain, dry skin, and hair.
- It may cause serious bleeding problem. Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
- Inform your doctor about the consumption of Svitinib 12.5 Capsule before going for surgical procedure.
- Do not take this medicine if you are pregnant, planning to conceive or breastfeeding.
FAQs
How should I take Svitinib 12.5 Capsule?
Does Svitinib 12.5 Capsule have any effect on skin and hair?
What is the most important thing I need to know about Svitinib 12.5 Capsule?
Are generics available for Svitinib 12.5 Capsule? How does Svitinib 12.5 Capsule work?
Can Svitinib 12.5 Capsule be used in combination with other chemotherapy medicines?
Does Svitinib 12.5 Capsule have any effect on blood sugar levels in diabetics?
Can Svitinib 12.5 Capsule cause any change in blood pressure?
How should I take Svitinib 12.5 Capsule?
Does Svitinib 12.5 Capsule have any effect on skin and hair?
What is the most important thing I need to know about Svitinib 12.5 Capsule?
Can Svitinib 12.5 Capsule be used in combination with other chemotherapy medicines?
Does Svitinib 12.5 Capsule have any effect on blood sugar levels in diabetics?
Can Svitinib 12.5 Capsule cause any change in blood pressure?
Are generics available for Svitinib 12.5 Capsule? How does Svitinib 12.5 Capsule work?
References:-
- U.S. Food and Drug Administration (FDA) – Drug Label (Sutent/Sunitinib):
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021938s13s17s18lbl.pdf
- (The FDA label confirming the 50mg dose and the 4-weeks-on/2-weeks-off (4/2) schedule as the recommended dosage for GIST and advanced RCC.)
- Philippines Food and Drug Administration (FDA) – Drug Registration (Example):
- https://verification.fda.gov.ph/ALL_DrugProductsview.php?showdetail=®istration_number=DRP-16439
- (Registration entry for Sunib 50mg Capsule (Sunitinib) in the Philippines FDA portal, confirming local approval and generic name.)
- NIH – PubMed Central (PMC) – Pivotal Trial Efficacy (GIST):
- https://www.scilit.com/publications/027fab2ef65b4141ac9d597db0e92c13
- (FDA Approval Summary detailing Sunitinib’s superior Time-to-Tumor Progression (TTP) and Objective Response Rate (ORR) compared to placebo in the pivotal Phase III GIST trial.)
- eviQ (Australian Cancer Guidelines) – Dosing Protocol:
- https://www.eviq.org.au/medical-oncology/urogenital/renal/322-renal-cell-metastatic-sunitinib
- (Official dosing protocol confirming the 50mg 4/2 regimen for Metastatic RCC and GIST, and detailing dose reduction strategies.)
- ResearchGate – Review on Management of Side Effects:
- https://researchers.mq.edu.au/en/publications/sunitinib-malate-in-the-treatment-of-renal-cell-carcinoma-and-gas/
- (Review focusing on Sunitinib malate and recommendations for patient management, side effect monitoring, and dose adjustments to handle common toxicities like hypertension and Hand-Foot Syndrome.)


Reviews
There are no reviews yet.